Roche Holding AG (RHHVF)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
At close: 12:29PM EDT
| Previous Close | 235.30 |
| Open | 238.06 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 237.29 - 240.41 |
| 52 Week Range | 234.20 - 323.78 |
| Volume | |
| Avg. Volume | 10,454 |
| Market Cap | 192.543B |
| Beta (5Y Monthly) | 0.15 |
| PE Ratio (TTM) | 15.20 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 10.86 (4.58%) |
| Ex-Dividend Date | Mar 14, 2024 |
| 1y Target Est | N/A |
- Zacks
Sarepta (SRPT) Q1 Earnings Beat Estimates, Revenues Up Y/Y
Sarepta (SRPT) reports better-than-expected Q1 earnings on the back of strong sales for recently-approved DMD gene therapy Elevidys.
- Thomson Reuters StreetEvents
Q1 2024 Sarepta Therapeutics Inc Earnings Call
Q1 2024 Sarepta Therapeutics Inc Earnings Call
- Zacks
Roche (RHHBY) Q1 Hit by Currency Headwinds, Lower COVID-19 Sales
Roche's (RHHBY) performance in first-quarter 2024 is pretty ho-hum as COVID-19-test sales continue to decline. The top line suffers due to the appreciation of the Swiss franc against most currencies.
© 2024 Yahoo. All rights reserved.